CURLF

King_Chron

just GTBIF, TCNNF, CURLF were the newly added ones

King_Chron

and CURLF

King_Chron

youre wrong, CURLF, TCNNF, GTBIF are now tradable

RogueJello

For those curious, it's read only atm, and only Trulieve (TCNNF), Curaleaf (CURLF), and Green Thumb Industries (GTBIF)

BoJo_Nose6969

what value does CURLF need to eclipse for that cross? thx

UsedState7381

It seems that now you can now buy GTBIF, TCNNF and CURLF on the Robinhood app https://x.com/i/status/2060327349611061732 Important to add: This is not uplisting, we are still on OTC, but broader exposure is always welcome. I'm thinking about resurrecting my old RH account just to see if I can place an order on Green Thumb...The problem is actually dealing with RH's overall shitty app.

AverageNo130

Opened a modest position on GTBIF today. As noted, closed my CURLF position yesterday. GLTA

UsedState7381

I mean, you were talking about Curaleaf initially, and Geo was saying they should raise money via dilution, I interjected that this would be fucking stupid since CURLF doesn't have the liquidity and volume that Tilray and CGC enjoys on the main exchanges.

Tiaan

It's interesting how people thought these names were being differentiated based on their % medical sales vs rec sales, but just a few weeks later, everything is back to normal where $CURLF continues to wildly outperform every other name on nearly every time frame

skyplt29

For me right now it is about the volume...or lack of it. CURLF is showing 78K on a daily average of 1.25M. MSOS is sitting at 3.2M on an average of 8.4M. These aren't run for the hills types of volumes, more of a "meh". I am about to shut down and enjoy the long weekend. I didn't think my sell orders would fill today (that's sarcasm, they start at about 2X today's prices and ratchet up to 3X or so). I am curious to see is MSOS finishes above or below 4.50. All it will do is further confirm how rigged this market is. Good weekend everyone. At some point this nightmare ends...

AverageNo130

fwiw from a post... You guys hear that [$JPM](https://stocktwits.com/symbol/JPM) is starting to custody [$CURLF](https://stocktwits.com/symbol/CURLF) stock? Was briefly mentioned on TDR yesterday. Have no other information about it.

PlumDumbCumGetchySum

I like all three. But all three have issues. GTBIF has super share structure issues that date all the way back to Pete Kadens. GTBIF has the best balance sheet, while controlling very nice margins. However, the footprint is too narrow and the branding is not the best. Trulieve overspent for Harvest Health Az. footprint, which telegraphed their main problem. Rivers has shown little improvement in diversification on a National Scale. Trulieve is far too dependent on Florida and they have spent a great deal to keep the advantage in the Sunshine State. TCNNF also has the worst ticker symbol and product recognition of the three. CURLF has spent far too much money in some awful markets (Michigan and California cost Curaleaf millions alone). The product lines are highly recognizable and branding gives Jordan a slight edge in marketability. The International set-up, and multi-state imprint IS the main difference here. However, the Russian sentiment and negative perception can hurt the Company’s popularity. In all likelihood, none of the three will end up like Hadley’s Ianthus. Hopefully they never Ass Cheeto some fake walls up, or Triple Diamond overbuild for a market the size of Brooklyn. They can all use a clean-up. The greasy pink slip shit is fading away. Positioning will be key. Transparency and bottom lines will lead the way.

PlumDumbCumGetchySum

I like all three. But all three have issues. GTBIF has super share structure issues that date all the way back to Pete Kadens. GTBIF has the best balance sheet, while controlling very nice margins. However, the footprint is too narrow and the branding is not the best. Trulieve overspent for Harvest Health Az. footprint, which telegraphed their main problem. Rivers has shown little improvement in diversification on a National Scale. Trulieve is far too dependent on Florida and they have spent a great deal to keep the advantage in the Sunshine State. TCNNF also has the worst ticker symbol and product recognition of the three. CURLF has spent far too much money in some awful markets (Michigan and California cost Curaleaf millions alone). The product lines are highly recognizable and branding gives Jordan a slight edge in marketability. The International set-up, and multi-state imprint IS the main difference here. However, the Russian sentiment and negative perception can hurt the Company’s popularity. In all likelihood, none of the three will end up like Hadley’s Ianthus. Hopefully they never Ass Cheeto some fake walls up, or Triple Diamond overbuild for a market the size of Brooklyn. They can all use a clean-up. The greasy pink slip shit is fading away. Positioning will be key. Transparency and bottom lines will lead the way.

Thumbszilla

CURLF should gap up nicely this morning with that 200% EPS beat after market close yesterday

Thumbszilla

It looks like MSOS is going to gap up this morning on the underlying CURLF 200% EPS beat yesterday; the remaining top 3 holdings report in the next day

PlumDumbCumGetchySum

CURLF just rang that Bell!!!

PlumDumbCumGetchySum

CURLF GTBIF and Trulieve are after hours, but ……. CRESCO is looking interesting. If you play earnings?

AverageNo130

Boris has worked hard to get CURLF into this position. These are exciting times.

Thumbszilla

From Gemini: The outlook for the AdvisorShares Pure US Cannabis ETF (**MSOS**) is currently dominated by a rapid-fire series of regulatory and financial milestones. Here are the key upcoming catalysts scheduled for the remainder of 2026: ## **1. Q1 2026 Earnings Season (May)** The top holdings in MSOS—the major Multi-State Operators (MSOs)—are scheduled to report their first-quarter results in early May. These calls will likely focus on "Day 1" impacts of the recent medical rescheduling and updated guidance on **Section 280E** tax savings. * **Curaleaf (CURLF):** May 5, 2026 * **Trulieve (TCNNF):** May 7, 2026 * **Green Thumb (GTBIF) / Verano (VRNOF):** Expected mid-May 2026 ## **2. Broader Rescheduling Hearings (June – July)** While the Department of Justice (DOJ) finalized the move of **medical cannabis** to Schedule III on April 23, 2026, a second, more significant phase is now in motion: * **June 29, 2026:** An expedited administrative hearing begins to consider reclassifying **all** marijuana (including adult-use/recreational) to Schedule III. * **July 15, 2026:** The mandated deadline for this hearing to conclude. A positive outcome here would theoretically apply federal tax relief to the entire revenue stream of MSOs, not just the medical portion. ## **3. The "Hemp Cliff" (November 12, 2026)** The **Continuing Appropriations and Extensions Act of 2026 (CAEA)** contains a "strict reinterpretation" of hemp that is a major tailwind for MSOs. * **The Impact:** This law narrows the definition of legal hemp, effectively banning many psychoactive hemp-derived products (like Delta-8) that have competed with licensed dispensaries. * **The Catalyst:** This is expected to drive significant market share back to the MSOs held within the MSOS ETF by removing "gray market" competition. ## **4. Uplisting & Institutional Inflows** With the finalization of Schedule III, the "custody hurdle" for major banks and institutional investors is beginning to lower. * **Exchange Uplisting:** Investors are watching for any moves by the TSX or potentially U.S. exchanges (NYSE/NASDAQ) to allow MSOs to uplist. * **SAFER Banking Act:** While rescheduling provides the regulatory framework, the passage of the SAFER Banking Act remains the primary "missing link" for full U.S. exchange access and traditional credit card processing. > **Note on 280E Relief:** Analysts estimate that the full implementation of Schedule III could improve EBITDA margins for major MSOs by **10–20 percentage points** due to the removal of the 280E tax penalty, which currently prevents cannabis businesses from deducting standard operating expenses. > What specific aspect of the MSOS holdings are you tracking most closely right now—is it the regulatory side or the technical price action?

Thumbszilla

Uhhh... $MSOS is surely about to start running.  Check out the list of upcoming earnings reports where the underlying companies of $MSOS should be flush with extra cash due to their varying degrees of last week's 280E end and possible upcoming refunds.  Guidance for these companies will likely be insane.  None of the Canadian companies benefit from it.  My prediction is that it's likely the last chance to get $MSOS shares in the $4.00's this week! $VRNO (6% of $MSOS): April 30th, 2026 $CURLF (28% of $MSOS): May 5th, 2026 $GTBIF (19% of $MSOS): May 6th, 2026 $TCNNF (25% of $MSOS): May 7th, 2026 $CRLBF (6% of $MSOS): May 8th, 2026 $GLASF (7% of $MSOS): May 12th, 2026 $TSNDF (4% of $MSOS): May 14th, 2026

Thumbszilla

Uhhh... MSOS is surely about to start running.  Check out the list of upcoming earnings reports where the underlying companies of MSOS should be flush with extra cash due to their varying degrees of last week's 280E end and possible upcoming refunds.  Guidance for these companies will likely be insane.  None of the Canadian companies benefit from it.  My prediction is that it's likely the last chance to get MSOS shares in the $4.00's this week! VRNO (6% of MSOS): April 30th, 2026 CURLF (28% of MSOS): May 5th, 2026 GTBIF (19% of MSOS): May 6th, 2026 TCNNF (25% of MSOS): May 7th, 2026 CRLBF (6% of MSOS): May 8th, 2026 GLASF (7% of MSOS): May 12th, 2026 TSNDF (4% of MSOS): May 14th, 2026

16semesters

> and if MSOS/GTBIF/TCNNF/CURLF can stop getting taxed to death OP made up that part about taxes. This doesn't effect taxes whatsoever. It's about making research easier.

wang4wang

OK, the business model is still ugly, but acting like rescheduling is nothing is dumb imo. 280E was absolutely crushing these names, and if MSOS/GTBIF/TCNNF/CURLF can stop getting taxed to death (finally), that’s not some tiny detail lol

tantedbutthole

I’m still holding MSOS, TLRY, CGC, CURLF, GTBIF, and TCNNF. I’m down like 50% but I’ll hold to the moon

BoJo_Nose6969

[https://www.youtube.com/watch?v=1zrOzSoCcJs](https://www.youtube.com/watch?v=1zrOzSoCcJs) some good perspective here on CURLF

Veganlightbody

Named insiders like the CEOs of GTBIF and CURLF were saying it's 100% 2026 but might take a little bit to make it safe against SAM legal bullshit.

TomorrowLow5092

CURLF has more debt than shares and more outstanding shares than all the rest. I'm no AI but the debt is too much.

AlbertiApop2029

TCNNF - Trulieve Big player in the Florida Market. In for 100 shares. Very nice stores, knowledgeable staff. Some DD: [Florida Cannabis Business: Navigating the Vertical Market](https://www.leafsheets.com/facts/florida-cannabis-business-navigating-the-vertical-market) [They have many stores here.](https://fldispensaries.com/trulieve-florida-dispensaries-delivery-menu-discounts-reviews-mmtc/) [They do have some debt, but I've heard the CEO is pretty good.](https://finance.yahoo.com/quote/TCNNF/balance-sheet/) Happy 4/20! Could check out [CURLF - Curaleaf ](https://ir.curaleaf.com/)too, I just liked [Trulieve](https://investors.trulieve.com/) better.

benderok37

100 shares $CURLF 50 shares $MSOS 

hambone_83

Don't shoot the messenger: # Moving to Very Large MSOS I am in the process of moving to very large in  ([**MSOS**](https://www.thestreet.com/quote/MSOS)) . **Position:** Long MSOS [By Doug Kass](https://pro.thestreet.com/author/doug-kass)Mar 18, 2026 4:01 PM EDT earlier in the day: \* I added to  ([**CURLF**](https://www.thestreet.com/quote/CURLF))  at $2.29 and  ([**MSOS**](https://www.thestreet.com/quote/MSOS))  at $3.81 @ 1:10pm

git0ffmylawnm8

Yeah, fuck it. CURLF and TLRY calls at market open. People are high as a kite and three sheets to the wind

AverageNo130

For example, CURLF began focusing on wholesale distribution a while ago. Seems like a good idea. Don't know the status of that plan or if other MSOs are doing likewise.

AlbertiApop2029

I was looking hard at CuRAleaf (CURLF) and TruLIEve today. [FL can't get it together](https://www.marijuanamoment.net/florida-voters-support-marijuana-legalization-new-poll-shows-as-state-officials-defend-invalidation-of-ballot-signatures/), but that was actually a positive for TruliEVE.

Russticale

Nice to see the pop today, I did buy the open on GTBIF and CURLF. Sold half way through the day, didn't realize GTBIF could break $6.50 and run. With plenty of upside exposure, hopefull I'll be fading this rally next week. Growing cash (hopefully) in expectation of our major rescheduling announcement and will be ready if it's positive or negative news.

Tiaan

Today's price action was mostly caused by $CURLF falling off of a cliff. I guess MSOS dumping most of their inflows into $CURLF over the past year to artificially pump it wasn't the best idea

JoeyTaTsNyC

Hate to add a negative post but I’m so sick of this sector and CURLF!!! I should have dumped when we hit $5 a couple weeks ago and scooped $50k. How knows when we will start seeing some serious gains. Holding tight but extremely rattled.

personman_76

Everybody invest in Oklahoma right now, holy money maker. I know a few places that are great, but avoid investing in CURLF and TCNNF, they're not likely to get past state legislatures for a few years and start producing. Oklahoma has a moratorium on new growers until August, so the big players here are the ones that are likely to stay on top. Invest in towns like Noble, or Moore, or Norman. There's a lot of industrial professors here and growers a few miles away, we grow 32x the amount of weed needed for the state consumption and are absolutely going to explode when it's allowed between states

PlumDumbCumGetchySum

MSOS rebalancing away from CURLF.

ComprehensiveKiwi489

I've been waiting for this for a while - I bought my weed stocks mainly in May / June, earlier in the year. These stocks have been absolutely crushed, and weed stocks seem to go in God-mode rallies every number of years (i.e. 2018, end of 2020, beg of 2021), where the underlying stocks can sometimes 5-10X (perhaps life changing money), and I had a feeling that Trump would eventually reschedule. Also, the latest hemp ban is good for the industry, because companies have been selling hemp with tons of THC for years, so that was taking away business from regular cannabis co's. We still have banking reform that can happen (i.e. being able to use CC to buy weed, and allowing these companies to be able to do business / get loans from major banks), and then the really big one, uplisting onto NYSE / Nasdaq. A lot of people like to buy TLRY, but they don't even benefit from US federal reform. The beneficiaries are the US companies which can only be found on OTC (i.e. GTBIF, TCNNF, VRNO, CURLF, etc.). All in all, I'm roughly around 2-3X on my buys, and am holding longer for more.

Tiaan

MSOS has bought over 10x as much CURLF this year as they have GTBIF

Tiaan

Crazy how MSOS now nearly has twice as much CURLF holdings (28%) than they do GTBIF (18%). Dan must really despise GTBIF. At this point it may be better if they just exit GTBIF completely

heliumbox

https://www.reddit.com/r/weedstocks/comments/1potoc2/daily_discussion_thread_december_17_2025/nuiksxe/ Not that surprising when Dan spends 3x as much on CURLF and more than double on TCNNF than GTBIF.

MidWestFineese

Sold CURLF and kept TLRY. . Lol, you are hilarious.

heliumbox

Held up much better yes. but has lagged every single move. TCNNF is nearly the same MC and CURLF is 50% higher. There is no reason GTBIF shouldn't have a value premium SIGNIFICANTLY higher than CURLF and definitely much higher than TCNNF when their financials are in a complete league of their own. There is nothing fairly valued about a company trading at a 50% discount to a less than 10%? revenue deficit while having 40% less debt to assets.

srhogan1984

You need to invest in American Cannabis. GTIBF, CURLF, TCNNF, VRNO, CRBLF or the ETF MSOS

heliumbox

It might be bias but bouncing my ideas off chat GTBIF is MASSIVELY undervalued relative to peers. Even 100% run on the thumb would put it at a ***cheap*** valuation to peers. 280e would massively boost their already solid earnings while barely getting the rest to survive. If GTBIF rerates at some point the gains will be YUGE. CURLF's move to the TSX is clearly proving extremely well played.

Many_Easy

I also own Curaleaf, but their symbol is CURLF.

Outside_Mix_1131

I purchased Canopy (CGC) a few days ago based on the news regarding possible reclassification. Check out CURLF as well. The others I can think of (TCNNF, ACB) are not penny stocks but I'm sure there are more that are.

mi_so_funny

BHST & CURLF. My guess is king cheeto will "let" his Israeli overlords grow the THC molecules in their bioreactors while his Russian billionaire buddy, Boris Johnson, sells it thru Curaleaf.

King_Chron

**📊 280E Tax Relief – Cannabis MSO Estimates (Rescheduling → Schedule III)** Rescheduling could remove 280E, letting companies deduct normal expenses. Analyst research (Zuanic, Water Tower, Whitney) shows potential annual savings: |Company|2025 Revenue|Est. 280E Savings| |:-|:-|:-| |Curaleaf (CURLF)|$1.3–1.5B|$150–200M| |Trulieve (TCNNF)|$1.1–1.3B|$120–180M| |Green Thumb (GTBIF)|$1.0–1.2B|$100–150M| |Verano (VRNOF)|$900–1,000M|$80–120M| |Cresco (CRLBF)|$800–900M|$70–100M| |Jushi (JUSHF)|$250–500M|Up to \~$514M| |Cannabist / Columbia Care|$300–360M|$35–50M| |Planet 13 (PLNHF)|$95–110M|$9–15M| |MariMed (MRMD)|$150–180M|$15–25M| **Takeaways:** * Total U.S. MSO tax savings could reach **$2–3B+ annually**. * Largest absolute beneficiaries: Curaleaf, Trulieve, Green Thumb. * High % upside: Jushi, Planet 13, MariMed. * Retroactive refunds are speculative; cash depends on DEA/HHS action & IRS guidance.

C_B_Doyle

Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

BoJo_Nose6969

There are credible and well-reasoned legal arguments asserting that Section 280E does not apply to purely intrastate, state-licensed cannabis operations. If the issue is fully litigated, I believe companies like Trulieve (TRUL) and Curaleaf (CURLF), along with other operators taking similar positions, would either prevail outright or at minimum see their 280E-related tax liabilities significantly reduced or eliminated.

C_B_Doyle

Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

Congress can pass a simple statutory directive ordering the DEA to remove cannabis from Schedule I within a fixed window, and because scheduling authority ultimately comes from the Controlled Substances Act, lawmakers can override the agency with a single amendment that bypasses the slow administrative process. Once removed from Schedule I, the FDA immediately gains freedom to run full clinical evaluations, allowing cannabis to enter the same medical review pipeline used for any other therapeutic, which reshapes how investors view long-term regulatory clarity. A congressional mandate would also trigger automatic coordination between the DEA, FDA, and HHS, because descheduling forces these agencies into a compliance posture rather than a discretionary one, eliminating the political bottleneck that normally stalls progress. That fast alignment is exactly what markets tend to reward, since it takes the uncertainty premium off U.S. cannabis operators and opens the door for mainstream institutions that have been waiting for a clear federal rule. Once the FDA enters the picture with formal pathways, insurers can legally reimburse cannabis-based treatments through standard medical benefit structures, and hospitals or major retail pharmacies can dispense products sourced from established operators. That shift converts cannabis from a fragmented state-only model into a federal healthcare product, positioning companies like MRMD, CURLF, and TCNNF to plug directly into the national distribution chains they’ve been structurally built for. Congress can also attach descheduling to a broader health or appropriations bill, a tactic used constantly to move policy changes without relying on standalone votes. That approach makes passage much easier, because it folds cannabis into routine legislative cycles, sidestepping headline political fights and letting the reform ride through on a must-pass vehicle—something markets interpret as near-guaranteed execution once language is included. All of this creates a straightforward pathway: congressional directive → DEA compliance → FDA evaluation → insurance coverage → mainstream pharmacy distribution → national scale for operators. For lawmakers, it’s one of the cleanest federal reforms available; for the sector, it’s a regulatory unlock that allows U.S. cannabis stocks to function like normal consumer-health companies instead of siloed state-restricted plays.

C_B_Doyle

Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

Congress could require the DEA to move cannabis out of Schedule I within 90 days, instantly opening the door for a full scientific review. Once it’s descheduled, the FDA would run a complete evaluation—clinical data, therapeutic applications, dosing ranges, safety profiles, manufacturing standards, purity requirements, and how cannabis fits into existing classes of regulated medicines. HHS would take those findings and issue a formal medical determination, creating a nationally recognized foundation for regulated therapeutic use. That shift unlocks insurance coverage because FDA and HHS recognition allows CMS and private insurers to treat cannabis like any other approved treatment. Hospitals, integrated health networks, and major pharmacy chains could then stock and dispense standardized, FDA-compliant formulations. Operators like MRMD, CURLF, and TCNNF—already functioning in tightly regulated state systems—could transition into federally compliant production, scaling supply across state lines and eventually into international medical markets under unified standards. The sequence becomes: Congress directs DEA → DEA deschedules → FDA defines medical standards → HHS certifies medical use → insurers reimburse → pharmacies and hospitals dispense → regulated producers supply a national and global market.

CaptAmericaCaveman

Any thoughts on the hemp-derived ban and the impact on cannabis stocks, industry....billions of revenue, taxes, and jobs/businesses, all crushed? Does anyone own any MSOs, or product-based stocks like $CURLF, $TLRY, $JUSHI, $GTBIF, $RYM, or $CRLBF...etc....? So 1 year before the ban is live... Might see some merging, acquisitions for consolidation. Not sure if they csn lobby and join forces to try to change the ban to taxes, regulations, with more well-defined standards, clear rules? Be great if the lawmakers would get off its ass and change the cannabis classification from a Schedule 1 to a Schedule 3...cannabis should become just like alcohol, why not...why would they not want the taxes, the small businesses, and the jobs needed??

Tiaan

It's largely due to MSOS bias. The ETF has way too much power over how flows into the sector are divvied up. To give you an idea, YTD through Sept 30th, MSOS bought the following ($ cost is rough estimate based on avg price, but share count is real): 27,763,839 shares of $CURLF: ~$58,000,000 USD 6,664,172 shares of $TCNNF: ~$36,000,000 USD 20,667,716 shares of $TSNDF: ~$16,000,000 USD 2,308,623 shares of $GLASF: ~$14,000,000 USD 15,286,863 shares of $CRLBF: ~$15,000,000 USD 13,150,626 shares of $VRNOF: ~$13,000,000 USD And finally, 1,160,328 shares of $GTBIF: ~$5,800,000 USD Dan, $MSOS ETF manager, despises Ben Kovler and GTI, and prefers to buy just about any other weed stock other than GTI for that reason. Fundamentals be damned

C_B_Doyle

Lawmakers could order the DEA to take cannabis off Schedule I within 90 days, clearing the way for FDA review and opening the door for insurance-covered access through hospitals and major pharmacies like Walgreens, Costco, and CVS, supplied by existing MSOs such as MRMD, CURLF, TCNNF, and others.

infinite_cura

$CURLF Officially SUB $2. You know what that means... IF MSOS can't save it by the EOD, then...

C_B_Doyle

MRMD could push higher with volume and news about Medical Cannabis. Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

I bought 50,000 of MRMD bc lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.

C_B_Doyle

CURLF just invested in a hemp thca store. Ouch.

Fearless_fx

Apple stocks app on CURLF. Not sure why the number would be so different.

Tiaan

I'd say so, yes. GTBIF was generally outperforming the ETF up until Kovler started his public spat with Dan the ETF manager on twitter, and basically ever since then GTBIF has been underperforming the ETF. It's not even difficult to see why this has been the case. The ETF has immense control over how flows into the sector get divvied up, as its the major source of volume into the OTC names. Looking at how the flows have been used this year, they've been mostly going into Dan's most beloved holding CURLF (which is why it's up over 300%+ this year) while he's been primarily selling GTBIF, and any in-kind GTBIF flows have been largely sold to get cash instead of shares. That alone is enough to create the performance discrepancy you noted given how little volume exists in the OTC names

Draphippo

Happy I stuck to my guns, sold profit last week predicating price suppression for massive OPEX today. Added 5 min before the close to [$GTBIF](https://x.com/search?q=%24GTBIF&src=cashtag_click) [$TCNNF](https://x.com/search?q=%24TCNNF&src=cashtag_click). New position in [$CURLF](https://x.com/search?q=%24CURLF&src=cashtag_click). [$MSOS](https://x.com/search?q=%24MSOS&src=cashtag_click) and the underlying continue to be predictable. Hoping for news soon, low options volume moving into Nov. I think there's room to run. Happy Friday.

OkBroccoli6524

Doing some buying today, MSOS and CURLF so far. The Fox News article is bullish to me. Holding until a decision comes out. The article mentions a decision is likely before year end.

UsedState7381

GTII and CURLF have to be following next up or otherwise this is grade A bullshit.

TipTopTrader

CURLF has locations in multiple European nations.

Tiaan

let me guess, 3 million shares of CURLF and a few thousand shares, if any, of GTI

Tiaan

Lol I completely forgot about CURLF being added to the TSX/SP index yesterday. Being added to the index doesn't seem to have really done much for price action so far

AverageNo130

Not familiar with this case. Your timing, right before CURLF is uplisted in Canada is noted.

UsedState7381

Volume is still shit but MSOS is up considerably on the daily, almost 8%. We still have the sour hour to get through and the daily EOD dump, but the chart is steadily going up on barely any selling. This might make the CURLF listing on the S&P/TSX index more interesting this Friday and Monday.

AverageNo130

CRON is now about 42 % avg daily vol. CURLF about 62 %. They seem to be on track to avg trading vol end of day.

AverageNo130

Modest add on the dip...CURLF

muchm001

CURLF

Sippypooh

CURLF and CRLBF are my MSO play. I just like their long term strategies and positions over the long hall. My opinion

JTakaMakaveli

I also own GTBIF, TCBBF, CURLF, CRLBF, etc. bought MRMD several years ago thinking they either take off or at worst are acquired by one of the above. With how low the stock price is it seems low risk and potentially very high reward.

th3_d13_is_c4st

Cannabis stocks high risk high reward right now. MSOX, MSOS, TLRY, CGC, TCNNF, and CURLF. The first two being ETFs with the first being a 2x leveraged one. The middle two Canadian companies and the latter two American companies. This is not financial advice…

Siks10

CURLF

Tiaan

MSOS fund managers are children who hate the GTI CEO, so they sell off the stock at every opportunity, while they fawn over CURLF and pump it as high as possible

ToastedDizguise

I just picked up 100 more shares of MSOS and 35 CURLF with the money left over. Both are well above my cost average but I hate when I wish I bought more

SampleHomeSapiens

Wow, over $20M in inflows yesterday into MSOS and about $20M in cash still left to deploy. MSOS bought 500K+ shares of GTBIF and TCNNF. And 1M+ shares of VRNOF, CRLBF, TSNDF, CBSTF and. of course, CURLF. What a day. https://x.com/junglejava1/status/1960540896346112463?s=46&t=R3FbbhS_l0lFIJt2nBUUiA

AverageNo130

CURLF spiked to $3.25 at 3:23. You know what that means, now $3.17.

HazelKittenDude

Still holding my cannabis stocks from 2021: VFF @ $18.41 CURLF @ $17.11 YOLO @ 29.18 Lost all with Red White & Bloom. Now it's just some cusip number. So yea, I'm ready for this industry to pop!!

BoJo_Nose6969

Hope it didn't go unnoticed that CURLF is scheduled to be included in the S&P/TSX Composite Index.  History shows inclusion often increases stock liquidity by 20-30% within six months, indicating potential price surges for $CURLF if guidance confirms September inclusion. 

Tiaan

$MSOS has bought millions of shares of $CURLF in the past few weeks while dumping hundreds of thousands of shares of other MSOs like $GTBIF and $TCNNF

Healthy_Equipment523

A rising tides lifts all boats. It's normal they deploy in riskier companies at this point, we are talking peanuts like 4m in CURLF. That's pocket change. The important part is that money is flowing massively in the sector.

AverageNo130

CURLF just popped to 107% daily vol. Will see if the usual last minute sell-off repeats today.

Meko1972

GTBIF TCNNF CURLF JAZZ a pharmaceutical company that has several marijuana based drugs.

boravuth

Fluent stock is still way underrated even though its shares are held more by insiders than any other MSO companies. Fluent shares: 36.43% held by insiders, 1.86% by institutions Compared to the top MSO companies. CURLF: 27.84% by insiders, 2.41% by institutions. TCNNF: 3.86% by insiders, 5.15% by institutions GTBIF: 1.86% by insiders, 14.24% by institutions. These figure are from Yahoo Finance.

jaesolo

And I sold half my CURLF when it was at .80. Ugh. It’s rebounded quite a bit.

AverageNo130

Added some CURLF on the dip today.

Starkiller32

I’m up 68.7% in CURLF. I’m holding this to the end.

tiorteD_snotsiP

CURLF thank me later.

PocketAces93

CURLF is almost +200%

AverageNo130

CURLF ER today. Call at 5:00 pm ET.

LandStander420

Dang! CURLF 2 million + traded GTBIF 1 million + traded TCNNF 1 million + traded